TBP — Tetra Bio Pharma Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareSpeculativeMicro Cap
Annual cashflow statement for Tetra Bio Pharma, fiscal year end - November 30th, CAD millions except per share, conversion factor applied.
2017 November 30th | 2018 November 30th | 2019 November 30th | 2020 November 30th | 2021 November 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -6.7 | -7.85 | -14.2 | -21.2 | -52.2 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 2.6 | -2.8 | -3.12 | -0.699 | 27.2 |
| Discontinued Operations | |||||
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.2 | 1.14 | -0.008 | 2.18 | -0.431 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Accrued Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Net Change in Other Assets & Liabilities | |||||
| Cash from Operating Activities | -3.89 | -9.51 | -17.3 | -19.6 | -25.3 |
| Capital Expenditures | -0.75 | — | -0.255 | -2.16 | -1.15 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | — | -2.13 | -3.43 | -1.26 | -0.966 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | -0.75 | -2.13 | -3.69 | -3.42 | -2.12 |
| Financing Cash Flow Items | -0.007 | -1.73 | 1.12 | -3.52 | -2.67 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 5.62 | 23 | 9.73 | 23.5 | 29.8 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.974 | 11.4 | -11.3 | 0.463 | 2.39 |